ReEngage Therapeutics, Inc. filed an amended Form D with the Securities and Exchange Commission on 2025-06-18.
ReEngage Therapeutics, Inc. filed an amended Form D notice of an exempt securities offering with the SEC on June 18, 2025. The filing reports $365K sold. Its industry group is Other Health Care. It names Thomas Kim (Executive Officer, Director) (SEC Form D/A, June 18, 2025).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like ReEngage Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-06-18 · the record
Pitching, partnering or investing alongside them? See who really runs and owns ReEngage Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind ReEngage Therapeutics, Inc., from the filings we hold.
Other Health Care raises by companies based in Texas, filed in June 2025, largest first.
Get an email when ReEngage Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when ReEngage Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch ReEngage Therapeutics, Inc. →Get the full cited report on ReEngage Therapeutics, Inc.
What the filing shows about ReEngage Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on ReEngage Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives ReEngage Therapeutics, Inc.'s address as 2450 Holcombe Blvd. Suite 1200, Houston, TX 77021.
Saved here on this device in the meantime, so nothing is lost either way.
Amended on 2025-07-01: the amount sold changed from $250,000 to $365,000; the number of investors changed from 1 to 6; proceeds used for payments to executive officers, directors or promoters changed from $0 to $25,000. Figures on this page are from the amendment. Amended filing · Original filing
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on ReEngage Therapeutics, Inc. See pricing
ReEngage Therapeutics, Inc. is a registered filer with the SEC (CIK 2022524) and has filed since 2024-12-16. 3 filings are on record, the latest on 2025-07-01.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
ReEngage Therapeutics, Inc.'s Form D of 2025-06-18 names Thomas Kim as its officers, directors or promoters.
Its new offerings report $315K sold across 2 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 869 filings in Other Health Care, totalled by week.
Thomas Kim is named as Executive Officer and Director on the Form D that ReEngage Therapeutics, Inc. filed with the SEC on 18 June 2025, the only person that filing names.
1 person named on the filing — 1 holding an executive role.
Named as of the 2025-06-18 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about ReEngage Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on ReEngage Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on ReEngage Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist ReEngage Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind ReEngage Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for ReEngage Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Health care raises in Houston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/reengage-therapeutics-inc-form-d-25000001